Michael Logerfo

Chief Operating Officer at Piramal Critical Care, Inc.

Michael Logerfo

Michael Logerfo

Chief Operating Officer at Piramal Critical Care, Inc.

Overview
Career Highlights

Piramal Critical Care, Inc.
Kanghong Sagent Chengdu Pharmaceutical Corp. Ltd.
Kuwait Saudi Pharmaceutical Industries Co. SAK

RelSci Relationships

130

Birthday

1965

Age

54

Number of Awards

2

Relationships
RelSci Relationships are individuals Michael Logerfo likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Executive Officer, Critical Care at Piramal Enterprises Ltd.

Relationship likelihood: Strong

Chief Operating Officer & President, Pharmaceutical Division at Athenex, Inc.

Relationship likelihood: Strong

Vice President & Controller at Sagent Pharmaceuticals Inc.

Relationship likelihood: Strong

Vice President-Regulatory Affairs at Sagent Pharmaceuticals Inc.

Relationship likelihood: Strong

Chief Financial Officer at BioQ Pharma, Inc.

Relationship likelihood: Strong

Former Executive Vice President-Sales at Sagent Pharmaceuticals Inc.

Relationship likelihood: Strong

Former Member-Deans Committee at Midwestern University

Relationship likelihood: Strong

Former Director, Scientific Development/Specialty Manufacturing at Cardinal Health, Inc.

Relationship likelihood: Strong

Former Chief Scientific Officer at Sagent Pharmaceuticals Inc.

Relationship likelihood: Strong

Former Senior Director-Pharmacy at Premier Healthcare Solutions, Inc.

Relationship likelihood: Strong

Paths to Michael Logerfo
Potential Connections via
Relationship Science
You
Michael Logerfo
Chief Operating Officer at Piramal Critical Care, Inc.
Career History
Chief Operating Officer
Current

Part of Piramal Enterprises Ltd., Piramal Critical Care, Inc. is a company headquartered in Bethlehem, PA, that manufactures anesthesia solutions. Peter DeYoung is the current CEO of the firm.

President
2007 - 2016

Sagent Pharmaceuticals, Inc. develops, manufactures, and markets pharmaceutical products. It offers injectable products such as amikacin sulfate, ampicillin and sulbactam, cefazolin, piperacillin and tazobactam, and vancomycin hydrochloride. The company was founded by Jeffrey M. Yordon in 2006 and is headquartered in Schaumburg, IL.

Chief Operating Officer
2007 - 2008

Kanghong Sagent Chengdu Pharmaceutical Corp. Ltd., a subsidiary of Nichi-Iko Pharmaceutical Co., Ltd., is a company headquartered in Chengdu, China. The firm manufactures and supplies pharmaceutical products. It was founded in 2006. Kanghong Sagent Chengdu Pharmaceutical Corp. Ltd. was acquired by Sagent Pharmaceuticals, Inc., now part of Nichi-Iko Pharmaceutical Co., Ltd. on 04 Jun 13 for $4.06 million.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$100 - $249
2010
Transactions
Details Hidden

Sagent Pharmaceuticals Inc. purchases Omega Laboratories Ltd.

Awards & Honors
Admitted to the New Jersey Bar
Admitted to the New York Bar
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Michael Logerfo. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Michael Logerfo's profile does not indicate a business or promotional relationship of any kind between RelSci and Michael Logerfo.